Konventionell symptomatisch und präventiv strategisch: Therapeutische optionen bei typ 1-diabetes

Michael Hummel; A. G. Ziegler

doi:10.1055/s-2005-864644

Konventionell symptomatisch und präventiv strategisch: Therapeutische optionen bei typ 1-diabetes

Translated title of the contribution: Conventional symptomatic and preventive strategic treatment: Therapeutic options in type 1 diabetes

Michael Hummel
, A. G. Ziegler

City Hospital Munich-Schwabing

Research output: Contribution to journal › Review article › peer-review

Abstract

The treatment aim in type 1 diabetes is to mimic the physiological insulin release by multiple injection therapy. Therefore, intensified conventional or insulin pump therapy with multiple insulin injections is used (ICT or CSII). These therapies aim to reach near normal blood glucose levels. New insulin analogues and structured patient education improved the therapeutic results. The DCCT showed a significant reduction of microvascular complications through ICT in comparison to conventional therapy (CT) with two injections of premixed insulin. It has been shown that preserving the beta cell reserve reduces complications of type 1 diabetes. Therefore, in future C-peptid preserving therapies will probably be important.

Translated title of the contribution	Conventional symptomatic and preventive strategic treatment: Therapeutic options in type 1 diabetes
Original language	German
Pages (from-to)	28-33
Number of pages	6
Journal	Notfall und Hausarztmedizin
Volume	31
Issue number	1-2
DOIs	https://doi.org/10.1055/s-2005-864644
State	Published - 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1055/s-2005-864644

Cite this

@article{7b2f3b28120e458ab2ea8a157762bae7,

title = "Konventionell symptomatisch und pr{\"a}ventiv strategisch: Therapeutische optionen bei typ 1-diabetes",

abstract = "The treatment aim in type 1 diabetes is to mimic the physiological insulin release by multiple injection therapy. Therefore, intensified conventional or insulin pump therapy with multiple insulin injections is used (ICT or CSII). These therapies aim to reach near normal blood glucose levels. New insulin analogues and structured patient education improved the therapeutic results. The DCCT showed a significant reduction of microvascular complications through ICT in comparison to conventional therapy (CT) with two injections of premixed insulin. It has been shown that preserving the beta cell reserve reduces complications of type 1 diabetes. Therefore, in future C-peptid preserving therapies will probably be important.",

author = "Michael Hummel and Ziegler, \{A. G.\}",

year = "2005",

doi = "10.1055/s-2005-864644",

language = "Deutsch",

volume = "31",

pages = "28--33",

journal = "Notfall und Hausarztmedizin",

issn = "1612-8591",

publisher = "Georg Thieme Verlag",

number = "1-2",

}

TY - JOUR

T1 - Konventionell symptomatisch und präventiv strategisch

T2 - Therapeutische optionen bei typ 1-diabetes

AU - Hummel, Michael

AU - Ziegler, A. G.

PY - 2005

Y1 - 2005

N2 - The treatment aim in type 1 diabetes is to mimic the physiological insulin release by multiple injection therapy. Therefore, intensified conventional or insulin pump therapy with multiple insulin injections is used (ICT or CSII). These therapies aim to reach near normal blood glucose levels. New insulin analogues and structured patient education improved the therapeutic results. The DCCT showed a significant reduction of microvascular complications through ICT in comparison to conventional therapy (CT) with two injections of premixed insulin. It has been shown that preserving the beta cell reserve reduces complications of type 1 diabetes. Therefore, in future C-peptid preserving therapies will probably be important.

AB - The treatment aim in type 1 diabetes is to mimic the physiological insulin release by multiple injection therapy. Therefore, intensified conventional or insulin pump therapy with multiple insulin injections is used (ICT or CSII). These therapies aim to reach near normal blood glucose levels. New insulin analogues and structured patient education improved the therapeutic results. The DCCT showed a significant reduction of microvascular complications through ICT in comparison to conventional therapy (CT) with two injections of premixed insulin. It has been shown that preserving the beta cell reserve reduces complications of type 1 diabetes. Therefore, in future C-peptid preserving therapies will probably be important.

UR - https://www.scopus.com/pages/publications/14344261514

U2 - 10.1055/s-2005-864644

DO - 10.1055/s-2005-864644

M3 - Übersichtsartikel

AN - SCOPUS:14344261514

SN - 1612-8591

VL - 31

SP - 28

EP - 33

JO - Notfall und Hausarztmedizin

JF - Notfall und Hausarztmedizin

IS - 1-2

ER -

Konventionell symptomatisch und präventiv strategisch: Therapeutische optionen bei typ 1-diabetes

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this